Identifying serum lipidomic signatures related to prognosis in first-episode schizophrenia
Abstract Background Antipsychotic medications are crucial for alleviating symptoms of schizophrenia (SCZ). However, treatment responses vary across individuals, and few reliable biomarkers currently exist to predict the clinical outcome. Therefore, we aim to identify potential lipid markers for trea...
Na minha lista:
| Principais autores: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2025-05-01
|
| coleção: | BMC Psychiatry |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1186/s12888-025-06802-7 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
